The Sohn Conference Foundation has announced a three-year, $1.5 million grant to Columbia University Medical Center in support of the center's precision pediatric cancer program.
In phase I/II trial, new targeted therapy for hard-to-treat chronic lymphocytic leukemia appears as effective as ibrutinib with fewer side effects.
CUMC Debuts Program for Those with Undiagnosed Disorders
Parents sometimes know there’s something wrong with their child, but the child’s constellation of symptoms doesn’t add up to a recognized diagnosis. The symptoms can make life difficult, but so can the lack of a diagnosis—and the treatment and support that go with it.